Savara Pharmaceuticals
SVRA
#7027
Rank
NZ$0.81 B
Marketcap
$4.73
Share price
-1.84%
Change (1 day)
-41.88%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -NZ$0.14 Billion

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$96.85 Million a decrease over its 2022 earnings that were of -NZ$67.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.14 Billion38.63%
2023 -NZ$96.85 Million43.38%
2022 -NZ$67.55 Million-11.31%
2021 -NZ$76.16 Million-13.3%
2020 -NZ$87.85 Million-36.53%
2019 -NZ$0.14 Billion13.76%
2018 -NZ$0.13 Billion105.54%
2017 -NZ$59.2 Million34.11%
2016 -NZ$44.14 Million-37.43%
2015 -NZ$70.55 Million38.81%
2014 -NZ$50.82 Million33.62%
2013 -NZ$38.04 Million38.49%
2012 -NZ$27.47 Million24.59%
2011 -NZ$22.05 Million-36.5%
2010 -NZ$34.71 Million-3.14%
2009 -NZ$35.84 Million-23.28%
2008 -NZ$46.71 Million8.52%
2007 -NZ$43.05 Million-34.14%
2006 -NZ$65.36 Million184.43%
2005 -NZ$22.98 Million90.75%
2004 -NZ$12.05 Million190.35%
2003 -NZ$4.15 Million11.64%
2002 -NZ$3.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$32.15 Million-78.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.21 Billion 42.09%๐Ÿ‡บ๐Ÿ‡ธ USA